How Open-Source Technologies Will Transform Digital Clinical Trials
HIT Consultant
FEBRUARY 13, 2024
Precedent exists for accelerating approval timelines during health emergencies such as the AIDs/HIV epidemic, where Compound S, a re-make of AZT, or azidothymidine, originally developed to fight cancer, became controversially fast-tracked after the discovery that it could block HIV activity.
Let's personalize your content